Pfizer Plans To Hike Price Of US COVID-19 Vaccine By 400 Percent

After the U.S. public health emergency ends, Pfizer plans to hike the price of the COVID-19 vaccine in the US by 400 percent.

According to the company's president in the United States, Angela Lukin, Pfizer intends to increase the cost of its COVID-19 vaccines in the country by up to four times after Washington's purchase plan ends.

The US government currently offers all Americans a free COVID-19 vaccination. When the U.S. public health emergency ends, private insurance will take over as the primary source of COVID-19 vaccine coverage. The Pfizer vaccination costs the federal government about $30 each dosage. Lukin anticipates that a dose will cost between $110 and $130 when the government purchasing scheme ends.

“We are confident that the U.S. price point of the COVID-19 vaccine reflects its overall cost-effectiveness and ensures the price will not be a barrier for access for patients,” Lukin said, according to Reuters.

By the first quarter of 2023, "at the earliest," ...

Limited Time

Full Access

$10
Monthly

Included:

  • Access to All Articles.
  • One Plan. No Tiers.
  • No Ads.
  • Cancel anytime.
register now

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].